Science Corporation implants vision-restoring chip in first Stargardt disease patient
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Science Corporation has implanted its vision-restoring chip in its first patient with Stargardt disease, a rare genetic eye disorder. The company, led by Max Hodak, former president and co-founder of Neuralink, detailed the milestone on stage at TechCrunch Disrupt, saying its work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
Continue in the app — vote & join in ➔Source: TechCrunch · via ahirlevel.hu